Navigation Links
Cytopia Scientific Presentation on JAK2 Inhibitor Program at American Chemical Society Conference
Date:3/23/2009

MELBOURNE, Australia, March 23 /PRNewswire/ -- Cytopia Limited (ASX: CYT) today announced that it will present data on its JAK2 program at the American Chemical Society Spring meeting, currently underway in Salt Lake City, Utah, USA.

Dr Tracy Nero, Senior Scientist at Cytopia, will be presenting the poster in the Division of Medicinal Chemistry's general poster session on Wednesday, March 25, 2009 from 7:00 PM to 9:00 PM (US ET), Salt Palace Convention Center, Hall 1.

The poster, entitled Small molecule inhibitors of Janus kinases describes preclinical data for a series of JAK2 inhibitors that lead to the identification of CYT387, the company's lead JAK2 drug candidate for the treatment of myeloprofilerative disorders (MPDs). Data for CYT387 in a panel of in vitro assays will be shown, as will comparative data with other described JAK inhibitors.

A separate poster on Cytopia's vascular disrupting agent (VDA), CYT997, has also been presented at the same conference.

About JAK2

The discovery of a specific single activating mutation in the JAK2 enzyme in MPDs in 2005 has focused attention on developing a therapy for these diseases through selective inhibition of JAK2. To successfully address these chronic diseases with a JAK2 inhibitor, the specificity and resultant tolerability profile is a key element of the product profile required for a "best in class" inhibitor.

Cytopia is a world leader in JAK2 kinase chemistry and holds a broad range of JAK2 related patents. The main focus of the JAK2 program is developing orally available JAK2 inhibitors to treat MPDs including myelofibrosis, polycythemia vera and essential thrombocythemia.

CYT387 is a specific JAK2 inhibitor with excellent potential for safe and efficacious chronic human dosing. It has been derived from Cytopia's knowledge of basic biology of JAK kinases, a strong structur
'/>"/>

SOURCE Cytopia Limited
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Cytopia Letter to Progen Shareholders
2. Cytopia and Other Progen Shareholders Maintain Call for Meeting
3. Presentation on Cytopias JAK2 Inhibitor Program in Myeloproliferative Disorders
4. Cytopia Strengthens Scientific Team With US-Based Drug Development Specialist
5. Cytopia Presentation on JAK2 Inhibitor at American Association for Cancer Research
6. Bio-Matrix Scientific Group, Inc. Gets Updated Stock Recommendation By KonLin Investment Letter
7. Joseph Loscalzo, M.D., PhD. to Join N30 Pharma Board and Chair Scientific Advisory Board
8. Boston Scientific Launches New Coronary Imaging Catheter
9. Milestone Scientific to Report 2008 Year-End Results on Tuesday, March 17, 2009
10. Moodys Raises Boston Scientifics Rating Outlook to Stable
11. Merrimack Pharmaceuticals Promotes Ulrik B. Nielsen, Ph.D. to Chief Scientific Officer and Edward J. Stewart to Senior Vice President of Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... Nasseo, Inc. today announces that it has ... hundreds of applicants by the Arizona Commerce Authority ... . The Arizona Innovation Challenge (AIC) awards the most ... granting a financial award to what it deems to ... of the art dental and orthopedic implant surface modification ...
(Date:6/18/2013)... June 18, 2013  AMRI (NASDAQ: ... Burlington, Mass. , site has received approval ... (DEA) registration to handle Schedule 2 and 2N ... of Burlington,s physical security ... (Logo: http://photos.prnewswire.com/prnh/20120229/NY61160LOGO ) ...
(Date:6/18/2013)... , June 18, 2013 ... has announced the addition of the report ... Companies " to their offering. ... briefly reviews basics of human genome variations, ... Current large and small sequencers are described ...
(Date:6/18/2013)... WA (PRWEB) June 18, 2013 Though ... -- 11,000, according to the U.S. Bureau of Labor Statistics ... increase of 24,000 per month. Most new health care jobs ... the hospital sector saw a loss of 6,000 jobs. Overall, ... outplacement consultancy firm Challenger, Gray & Christmas reported that a ...
Breaking Biology Technology:Nasseo Named 2013 Innovation Challenge Winner by Arizona Commerce Authority 2AMRI Burlington Receives DEA Approval to Handle Controlled Substances 2DNA Sequencing: Technologies, Markets and Companies - 2013 Report 2MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 2MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 3
... China, April 4, 2008 /Xinhua-PRNewswire-FirstCall/ -- WuXi,PharmaTech ... PharmaTech"), a leading,pharmaceutical, biotechnology and medical device ... China and the United States, today,announced that ... Form F-1 with the,Securities and Exchange Commission ...
... April 4, 2008 Scientists in fields,as diverse ... from the Olympus FluoroPoint(TM) single molecule fluorescence,detection system ... of laboratories around the world, the system, with ... of use, is now,available for the first time ...
... (Nasdaq: IDMI ) announced today the appointment of ... 3, 2008. Mr. Tibbitts is,currently the chief financial officer ... medical device company and in this role has overseen ... as from a clinical,stage company to the current commercial ...
Cached Biology Technology:WuXi PharmaTech (Cayman) Inc. Announces Filing of Registration Statement For Follow-On and Secondary Offering 2Olympus FluoroPoint(TM) System Provides High-Sensitivity Single Molecule and Protein Interaction Analysis for Screening and Research 2Olympus FluoroPoint(TM) System Provides High-Sensitivity Single Molecule and Protein Interaction Analysis for Screening and Research 3IDM Pharma Appoints Gregory J. Tibbitts to Board of Directors 2IDM Pharma Appoints Gregory J. Tibbitts to Board of Directors 3
(Date:6/17/2013)... French . A ... Alzheimer,s disease can be reversed with treatment. The study by ... Neuro, at McGill University and at Universit de Montral found ... brain of mice with advanced Alzheimer,s disease (AD) recovers memory ... of Neuroinflammation in May, also suggest an underlying mechanism ...
(Date:6/16/2013)... together and move around the body called ,chase and ... scientists at UCL. , Published in Nature Cell ... occurs when cancer cells interact with healthy cells in order ... cancer cells recruit healthy cells and use them to travel ... it could be controlled to design new therapies against cancer ...
(Date:6/14/2013)... students have difficulty understanding and explaining how evolution ... the subject, researchers at Michigan State University developed ... the molecular changes underlying an evolving characteristic to ... researchers, Peter J. T. White, Merle K. Heidemann, ... the scenarios into a cellular and molecular biology ...
Breaking Biology News(10 mins):Blocking overactive receptor in Alzheimer's recovers memory loss and more 2'Chase and run' cell movement mechanism explains process of metastasis 2Teaching complete evolutionary stories increases learning 2
... Biotechnology and Biological Sciences Research Council (BBSRC) at the University ... explain why the earliest evidence of complex multicellular animal life ... on the planet rose sharply from 3% to their modern ... Chris Schofield, has found that humans share a method of ...
... indicates an increased risk for developing breast cancer can ... according to a new study featuring work from researchers ... and their colleagues. The multidisciplinary team found that ... more likely to be present in breast cancer patients ...
... 2010) Whitehead Institute Founding Member Rudolf Jaenisch has been ... Massachusetts General Hospital (MGH). By tradition, the ... the prize with Dr. Shinya Yamanaka, who is on the ... Institutes in San Francisco. "The Warren Prize is the ...
Cached Biology News:550 million years ago rise in oxygen drove evolution of animal life 2Key information about breast cancer risk and development is found in 'junk' DNA 2Key information about breast cancer risk and development is found in 'junk' DNA 3Whitehead Member Rudolf Jaenisch to receive MGH's Warren Triennial Prize 2
Mouse polyclonal antibody to MCFD2 - multiple coagulation factor deficiency 2...
Anti (porcine) Vitronectin...
... to work in collaboration with Pall Life ... filters in a variety of membrane chemistries. ... use on the Caliper TPWII, MultiDose, Prelude, ... for our Automation Certified Syringe Filters are ...
... to BMP2 BMP2 belongs to ... superfamily. Bone morphogenic protein induces bone ... for the autosomal dominant disease of ... Immunogen: Synthetic peptide: PSDEVLSEFELRLLSM conjugated ...
Biology Products: